Cliical Trials: Documentation for Regulators

Case Studies: Regulatory Feedback on RBM Submissions in US, EU and UK In the realm of clinical research, the integration of a Risk-Based Monitoring (RBM) approach has been increasingly emphasized by regulatory authorities such as the FDA, EMA, and MHRA. This article aims to provide a comprehensive overview of the regulatory feedback on RBM submissions…

Read More “Case Studies: Regulatory Feedback on RBM Submissions in US, EU and UK” »

Checklists for RBM Documentation Before Major Health Authority Meetings Checklists for RBM Documentation Before Major Health Authority Meetings Introduction to Risk-Based Monitoring (RBM) in Clinical Trials Risk-Based Monitoring (RBM) is a strategic approach utilized during the conduct of clinical trials, particularly in phase 3b clinical trials. This method emphasizes the prioritization of critical data for…

Read More “Checklists for RBM Documentation Before Major Health Authority Meetings” »

Incorporating RBM into Risk Management Plans and DSURs In the evolving landscape of clinical research, the adoption of Risk-Based Monitoring (RBM) frameworks has become crucial, particularly in the context of ensuring comprehensive risk management. This tutorial provides clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU with a step-by-step guide…

Read More “Incorporating RBM into Risk Management Plans and DSURs” »

Using Metrics and Case Examples to Strengthen RBM Justifications Risk-Based Monitoring (RBM) has become a crucial methodology in the realm of clinical trial management. By using advanced metrics and case examples, clinical research professionals can effectively justify the adoption of RBM strategies to regulators. This tutorial will provide detailed steps, practical examples, and a comprehensive…

Read More “Using Metrics and Case Examples to Strengthen RBM Justifications” »

Harmonizing RBM Narratives Across Global Regulatory Submissions Harmonizing RBM Narratives Across Global Regulatory Submissions Introduction to Risk-Based Monitoring in Clinical Trials Risk-Based Monitoring (RBM) is an essential paradigm in modern clinical trial management, enabling sponsors and clinical research organizations (CROs) to address inefficiencies inherent in traditional monitoring methods. By emphasizing the identification, assessment, and mitigation…

Read More “Harmonizing RBM Narratives Across Global Regulatory Submissions” »

Common Documentation Gaps That Undermine Confidence in RBM Programs Common Documentation Gaps That Undermine Confidence in RBM Programs The transition to Risk-Based Monitoring (RBM) has transformed the clinical trial landscape, promising enhanced efficiency and improved data quality. However, the effective implementation of RBM programs hinges critically on meticulous documentation. In this step-by-step tutorial, we will…

Read More “Common Documentation Gaps That Undermine Confidence in RBM Programs” »